Abstract: A method of reprogramming omental adipose cells to a subcutaneous-like lineage is presented herein. The method comprises exposing omental adipose cells to a small molecule such as Basic Fibroblast Growth Factor (bFGF); TRC105; long noncoding RNAs (lncRNAs) MALAT1, GAS5, linc-VLDLR; transcription factors Sox15, Oct4, KLF4, Nanog, Sal4, BMI1; or combinations thereof.
Type:
Grant
Filed:
July 11, 2017
Date of Patent:
February 5, 2019
Assignees:
University of South Florida, The United States of America as Represented by the Department of Veterens Affairs
Abstract: Modifications of vitamin K-dependent polypeptides that lead to enhanced protein function on a weight or molar basis and/or increase of protein lifetime in the circulation are described. Both objectives are important for using vitamin K-dependent polypeptides for pro- and anti-coagulation therapies, as well as for other uses in the circulation.
Type:
Grant
Filed:
April 4, 2007
Date of Patent:
January 21, 2014
Assignees:
Regents of the University of Minnesota, The United States of America as represented by Department of Veterens Affairs
Inventors:
Gary L. Nelsestuen, Ronald Bach, Matthew Stone, Stephen Barrett Harvey
Abstract: The present invention relates to reversible hydrogel systems for medical applications. Particularly, the hydrogel of the present invention is made up of copolymers that can be a hydrogel when in an oxidized state and can be a solution when in a reduced state. A solution of the copolymer can be oxidized to form a hydrogel; and the hydrogel can be reduced to form a solution of the copolymer. The solution can be dehydrated to produce the dry copolymer for storage. Furthermore, the present invention also relates to methods of making and using the reversible hydrogel systems.
Type:
Grant
Filed:
November 13, 2003
Date of Patent:
June 5, 2012
Assignees:
The United States of America, as represented by the Department of Veterens Affairs, The Washington University in St. Louis